Clinical Trial

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Combination with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis (PBC)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-24.
Trial Details
NCT Number NCT06755151
Lead Sponsor Xijing Hospital of Digestive Diseases
Conditions Primary Biliary Cholangitis (PBC)
Enrollment 300 participants
Start Date 2024-01-17
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-08